Multi-site evaluation of partnered pharmacist medication charting and in-hospital length of stay.
internal medicine
medication error
medication safety
pharmacist
prescribing
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
14
05
2019
revised:
25
08
2019
accepted:
02
09
2019
pubmed:
22
10
2019
medline:
29
7
2021
entrez:
22
10
2019
Statut:
ppublish
Résumé
To undertake a multicentre evaluation of translation of a partnered pharmacist medication charting (PPMC) model in patients admitted to general medical units in public hospitals in the state of Victoria, Australia. Unblinded, prospective cohort study comparing patients before and after the intervention. Conducted in seven public hospitals in Victoria, Australia from 20 June 2016 to 30 June 2017. Patients admitted to general medical units were included in the study. Medication charting by pharmacists using a partnered pharmacist model was compared to traditional medication charting. The primary outcome variable was the length of inpatient hospital stay. Secondary outcome measures were medication errors detected within 24 h of the patients' admission, identified by an independent pharmacist assessor. A total of 8648 patients were included in the study. Patients who had PPMC had reduced median length of inpatient hospital stay from 4.7 (interquartile range 2.8-8.2) days to 4.2 (interquartile range 2.3-7.5) days (P < 0.001). PPMC was associated with a reduction in the proportion of patients with at least 1 medication error from 66% to 3.6% with a number needed to treat to prevent 1 error of 1.6 (95% confidence interval: 1.57-1.64). Expansion of the partnered pharmacist charting model across multiple organisations was effective and feasible and is recommended for adoption by health services.
Identifiants
pubmed: 31631393
doi: 10.1111/bcp.14128
pmc: PMC7015749
doi:
Banques de données
ANZCTR
['ACTRN12616000961448']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-290Subventions
Organisme : Department of Health and Human Services Victoria
Pays : International
Informations de copyright
© 2019 The British Pharmacological Society.
Références
Ann Emerg Med. 2001 Dec;38(6):666-71
pubmed: 11719747
Ann Pharmacother. 2013 Dec;47(12):1599-610
pubmed: 24259613
Drug Saf. 2009;32(5):379-89
pubmed: 19419233
Clin Med (Lond). 2012 Apr;12(2):119-23
pubmed: 22586784
Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
pubmed: 18179993
Mayo Clin Proc. 2014 Aug;89(8):1116-25
pubmed: 24981217
J Clin Pharm Ther. 2016 Aug;41(4):414-8
pubmed: 27255463
PLoS One. 2017 Feb 13;12(2):e0170495
pubmed: 28192477
Res Social Adm Pharm. 2014 Jul-Aug;10(4):679-92
pubmed: 24210425
Med Care. 1989 Feb;27(2):112-29
pubmed: 2918764
PLoS One. 2014 Jan 03;9(1):e79802
pubmed: 24404122
Br J Clin Pharmacol. 2020 Feb;86(2):285-290
pubmed: 31631393
Australas Emerg Nurs J. 2015 Aug;18(3):149-55
pubmed: 26012888
BMJ Open. 2017 Mar 16;7(3):e013647
pubmed: 28302636
J Gerontol A Biol Sci Med Sci. 2006 May;61(5):511-5
pubmed: 16720750
Med J Aust. 2008 Mar 3;188(5):267-8
pubmed: 18312186